+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06012760

Study of Combined Iron Sucrose, Erythropoietin, and Vitamin C to Reduce Blood Transfusions in Adults Undergoing Major Cardiac Surgery

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2026-06-02

400

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether a combined iron supplementation regimen can reduce the need for blood transfusions in adults with iron-deficiency anemia undergoing major elective cardiac surgery. The study compares this combined protocol to standard care to assess its safety, tolerance, and ability to lower allogeneic red blood cell transfusion during and shortly after surgery. Participants in the experimental group will receive intravenous iron sucrose 200 mg, subcutaneous recombinant human erythropoietin 150 IUkg, and intravenous vitamin C 2 g once daily for three consecutive days within the week before surgery. The control group will receive routine perioperative management based on clinical judgment. The treatment is given prior to major cardiac surgery such as coronary artery bypass grafting or valve surgery. During the study, participants will be monitored from hospital admission through 90 days after surgery. Assessments include blood transfusion volume from surgery start until five days post-surgery, changes in hemoglobin, ferritin, transferrin saturation, reticulocyte levels, quality of life, complications, mortality rates, and hospital and ICU stays. Transfusion decisions follow strict guidelines based on hemoglobin levels and signs of anemia or instability.

CONDITIONS

Brief Title

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here